Recently, it was reported that IL-1β gene promoter single nucleotide polymorphisms (IL-1β secretory phenotype) are associated with an increased risk for pancreatic cancer [19] and that IL-1β participates in opioid-resistant pain, such as bone cancer and neuropathic pain [22-27]. The gene discussed is IL1B; the disease is familial pancreatic carcinoma.